Imaging Study for Adrenal Gland Using [18F]FNP-59
Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1)
Recruiting
Early Phase 1
Interventional Study
Radiotracer
Hypertension
Cholesterol
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 6 (estimated)
- Sponsor
- Benjamin Viglianti · Other
Who this trial is looking for
This trial is looking for healthy volunteers to help evaluate a new imaging method for the adrenal gland. Participants will receive a small amount of a radioactive substance to see how it works in the body.
Are You a Good Fit for This Trial?
You may be able to join if
- I do not have any known adrenal problems
You may not be able to join if
- I am pregnant
- I cannot do imaging
- I weigh more than 400 lbs
- I am a prisoner
- I cannot give my own consent
- I use steroids or certain hormonal medications
- I have known adrenal pathology
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This exploratory, first-in-man, phase 0 study will evaluate the feasibility of using a sub-therapeutic dose of a fluorine-18 analogue of NP-59 (\[18F\]FNP-59) to image the adrenal gland in healthy normal subjects. The researchers believe that \[18F\]FNP-59 would greatly improve the imaging characteristics, by providing a PET imaging cholesterol analogue with significantly improved radiation dosime…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participants without any known adrenal pathology as normal controls for radiation dosimetry purposes
Exclusion Criteria:
* Pregnancy
* Unable to do imaging
* Body weight greater than 400 lbs (181 Kg)
* Prisoners are not eligible
* Subjects unable to provide own consent are n…
Contacts